Dermatology

Login Register

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Home

aurobindo-pharma

Tag: Aurobindo pharma

Read all Latest developments, information and news on and about Aurobindo-pharma

Aurobindo Pharma is a pharmaceutical manufacturing company headquartered in Hyderabad manufacturing generic pharmaceuticals and active pharmaceutical ingredients. - Latest Updates

USFDA Concludes Inspection of Aurobindo Pharma Subsidiary with 2 Observations

Parthika Patel30 Jun 2026 5:54 PM IST

New Delhi: Aurobindo Pharma Limited has informed the stock exchanges that the United States Food and Drug Administration (USFDA) has completed an...

USFDA Taps Indian Pharma to Ease Ifosfamide Shortage, Zydus, Cipla Among Key Suppliers

Parthika Patel26 Jun 2026 4:34 PM IST

New Delhi: Indian pharmaceutical companies are preparing to supply ifosfamide injection, an essential chemotherapy medicine, to the United States...

Aurobindo Pharma Secures FTC Approval for USD 250 Million Lannett Acquisition

Parthika Patel22 Jun 2026 5:43 PM IST

Hyderabad: Aurobindo Pharma Limited has announced that its wholly owned subsidiary, Aurobindo Pharma USA, Inc., has received approval from the United...

Aurobindo's Eugia Steriles Gets 5 USFDA Observations After Pre-Approval Inspection

Parthika Patel20 Jun 2026 9:39 PM IST

Hyderabad: Aurobindo Pharma Limited has informed the stock exchanges that the United States Food and Drug Administration (USFDA) has completed a...

Aurobindo Must Sell Four Drug Assets to Complete Lannett Buyout, Says FTC

Aurobindo Must Sell 4 Drug Assets to Complete USD 250 Million Lannett Buyout, Says FTC

Farhat Nasim19 Jun 2026 11:00 AM IST

New Delhi: The U.S. Federal Trade Commission is ‌requiring Aurobindo Pharma Limited to divest four different generic drug products to complete its...

Aurobindo Pharma's Eugia Unit-III Receives OAI Status from USFDA

Parthika Patel13 Jun 2026 10:30 AM IST

Hyderabad: Aurobindo Pharma Limited has informed stock exchanges that the United States Food and Drug Administration (USFDA) has classified its wholly...

Aurobindo Bets Big on Biologics, Inaugurates TheraNym Manufacturing Hub in Telangana

Parthika Patel6 Jun 2026 11:36 PM IST

New Delhi: Aurobindo Pharma has inaugurated TheraNym, one of India's largest dedicated biologics contract manufacturing organisations (CMOs), marking...

USFDA Clears Aurobindo Pharma's Generic Xeljanz Tablets for Arthritis, Ulcerative Colitis

sheeba farhat5 Jun 2026 5:57 PM IST

New Delhi: Aurobindo Pharma Limited has announced that it has received a final approval from the US Food & Drug Administration (USFDA) to...

Aurobindo's Eugia Unit-I Receives OAI Classification After 4 USFDA Observations

Parthika Patel26 May 2026 6:23 PM IST

New Delhi: Aurobindo Pharma has informed the stock exchanges that the United States Food and Drug Administration (USFDA) has classified Unit-I of...

Aurobindo Pharma FY26 Revenue Tops Rs 33,600 Cr, Europe Sales Surge 30%

Parthika Patel24 May 2026 11:30 AM IST

New Delhi: Aurobindo Pharma has reported a consolidated net profit of Rs 921 crore for the fourth quarter of FY26, while revenue from operations rose...

Telangana HC Dismisses Aurobindo Promoters' Plea in Rs 6.53 Crore Insider Trading Case

Parthika Patel18 May 2026 11:40 PM IST

New Delhi: Aurobindo Pharma has informed stock exchanges that the Telangana High Court has dismissed a writ petition filed by certain promoter and...

CDSCO Approves Aurobindo CuraTeQ's Bevacizumab Biosimilar Bevqolva for Cancer Treatment

Parthika Patel17 May 2026 10:22 PM IST

New Delhi: Aurobindo Pharma on Friday announced that its wholly owned subsidiary CuraTeQ Biologics Pvt Ltd has received marketing authorisation from...

Journal Club Today

Health News Today

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok